- Attilia F.; Perciballi R.; Rotondo C.; Capriglione I.; Iannuzzi S.;
Attilia M.L.; Coriale G.;Attilia M.L.
Harvested from ORCID Public Data FileAttilia M.L. in OpenAIRE Vitali M.; Cereatti F.; Fiore M.; Ceccanti M.; Addolorato G.; Aliotta V.; Alessandrini G.; Barletta G.; Battaglia E.; Battagliese G.; Carito V.; Casciani O.; Casella P.; Cesarini F.; Cibin M.; Ciccarelli R.; Ciolli P.; Di Prinzio A.; Fagetti R.; Falconi E.; Federico M.; Ferraguti G.; Fiorentino D.; Gencarelli S.; Giuliani A.; Greco A.; Intaschi G.; Janiri L.; La Torre G.; Lagrutta A.;Ferraguti G.
Harvested from ORCID Public Data FileFerraguti G. in OpenAIRE Laviola G.; Ledda R.; Leggio L.; Leonardi C.; Loffreda A.; Lugoboni F.; Macri S.; Mancinelli R.; Marconi M.; Maremmani I.; Maviglia M.;Laviola G.
Harvested from ORCID Public Data FileLaviola G. in OpenAIRE Messina M.P.; Mistretta M.; Montesano F.; Pascale E.; Parisi M.; Pisciotta F.; Spinnato G.; Valchera A.; Zavan V.;Messina M.P.
Harvested from ORCID Public Data FileMessina M.P. in OpenAIREAlcohol withdrawal syndrome (AWS) is a medical emergency, rare in the general population, but very common among alcoholic individuals, which can lead to severe complications when unrecognized or late treated. It represents a clinical condition which can evolve in few hours or days following an abrupt cessation or reduction of alcohol intake and is characterized by hyperactivity of the autonomic nervous system resulting in the development of typical symptoms. According to DSM-5 criteria, the alcohol withdrawal syndrome is defined as such: if patients present at least two of typical signs and symptoms. The Clinical Institute Withdrawal Assessment of Alcohol Scale, revised version (CIWA-Ar), is the tool for assessing the severity of AWS. The support to patient with AWS includes pharmacological intervention as well as general support, restoration of biochemical imbalances and specific therapy. Regarding the pharmacological treatment, benzodiazepines represent the gold standard, in particular long-acting benzodiazepines, administered with a gradual reduction up to cessation.
14 citations 14 popularity Top 10% influence Average impulse Top 10% 
Powered by BIP!add ClaimPlease grant OpenAIRE to access and update your ORCID works.This Research product is the result of merged Research products in OpenAIRE.
You have already added works in your ORCID record related to the merged Research product.This Research product is the result of merged Research products in OpenAIRE.
You have already added works in your ORCID record related to the merged Research product.<script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://beta.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=10.1708/2925.29413&type=result"></script>'); --> </script>For further information contact us at helpdesk@openaire.eu
